Academic Journal

Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS

التفاصيل البيبلوغرافية
العنوان: Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS
المؤلفون: Xiaocui Wu, Guangkun Tan, Jinghui Yang, Yinjuan Guo, Chengchen Huang, Wei Sha, Fangyou Yu
المصدر: International Journal of Infectious Diseases, Vol 121, Iss , Pp 47-54 (2022)
بيانات النشر: Elsevier, 2022.
سنة النشر: 2022
المجموعة: LCC:Infectious and parasitic diseases
مصطلحات موضوعية: Drug-resistant tuberculosis, Nucleotide MALDI-TOF-MS, Antimicrobial susceptibility testing, Drug resistance, Infectious and parasitic diseases, RC109-216
الوصف: ABSTRACT: Objectives: To evaluate the performance of nucleotide matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in predicting the drug resistance of Mycobacterium tuberculosis. Methods: A total of 115 rifampin-resistant and 53 rifampin-susceptible tuberculosis (TB) clinical isolates were randomly selected from TB strains stored at -80℃ in the clinical laboratory of Shanghai Pulmonary Hospital. Nucleotide MALDI-TOF-MS was performed to predict the drug resistance using phenotypic susceptibility as the gold standard. Results: The overall assay sensitivities and specificities of nucleotide MALDI-TOF-MS were 92.2% and 100.0% for rifampin, 90.9% and 98.6% for isoniazid, 71.4% and 81.2% for ethambutol, 85.1% and 93.1% for streptomycin, 94.0% and 100.0% for amikacin, 77.8% and 99.3% for kanamycin, 75.0% and 93.3% for ofloxacin, and 75.0% and 93.3% for moxifloxacin. The concordances between nucleotide MALDI-TOF-MS antimicrobial susceptibility testing (AST) and phenotypic AST were 94.6% (rifampin), 90.1% (isoniazid), 79.2% (ethambutol), 89.9% (streptomycin), 99.4% (amikacin), 97.0% (kanamycin), 88.1% (ofloxacin), and 88.0% (moxifloxacin). Conclusion: Nucleotide MALDI-TOF-MS could be a promising tool for rapid detection of Mycobacterium tuberculosis drug sensitivity to rifampin, isoniazid, ethambutol, streptomycin, amikacin, kanamycin, ofloxacin, and moxifloxacin.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1201-9712
Relation: http://www.sciencedirect.com/science/article/pii/S1201971222002612; https://doaj.org/toc/1201-9712
DOI: 10.1016/j.ijid.2022.04.061
URL الوصول: https://doaj.org/article/23ce5adc2ea442928c0753023f54029c
رقم الانضمام: edsdoj.23ce5adc2ea442928c0753023f54029c
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:12019712
DOI:10.1016/j.ijid.2022.04.061